References
Buziau AM, Schalkwijk CG, Stehouwer CDA et al (2019) Recent advances in the pathogenesis of hereditary fructose intolerance: implications for its treatment and the understanding of fructose—induced non: alcoholic fatty liver disease. Cell Mol Life Sci. https://doi.org/10.1007/s00018-019-03348-2
Distefano JK (2019) Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis. Cell Mol Life Sci 1:3. https://doi.org/10.1007/s00018-019-03390-0
Lanaspa MA, Johnson RJ, Tolan DR et al (2018) Ketohexokinase C blockade ameliorates fructose-induced metabolic dysfunction in fructose-sensitive mice find the latest version: Ketohexokinase C blockade ameliorates fructose- induced metabolic dysfunction in fructose-sensitive mice. J Clin Invest 128:2226–2238
Patel C, Douard V, Yu S et al (2015) Transport, metabolism, and endosomal trafficking dependent regulation of intestinal fructose absorption. FASEB J 29:4046–4058. https://doi.org/10.1096/fj.15-272195
Jang C, Hui S, Lu W et al (2018) The small intestine converts dietary fructose into glucose and organic acids. Cell Metab 27:351–361.e3. https://doi.org/10.1016/j.cmet.2017.12.016
Zhang X, Grosfeld A, Williams E et al (2019) Fructose malabsorption induces cholecystokinin expression in the ileum and cecum by changing microbiota composition and metabolism. FASEB J. https://doi.org/10.1096/fj.201801526RR
Demirbas D, Brucker WJ, Berry GT (2018) Inborn errors of metabolism with hepatopathy. Pediatr Clin North Am 65:337–352. https://doi.org/10.1016/j.pcl.2017.11.008
Aldamiz-Echevarria L, de Heraslas J, Couce ML et al (2019) Clinical nutrition non-alcoholic fatty liver in hereditary fructose intolerance. Clin Nutr. https://doi.org/10.1016/j.clnu.2019.02.019
Di DF, Spadarella S, Puoti MG et al (2019) Daily fructose traces intake and liver injury in children with hereditary fructose intolerance. Nutrients 11:1–12. https://doi.org/10.3390/nu11102397
Schwarz J-M, Noworolski SM, Erkin-Cakmak A et al (2017) Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity. Gastroenterology 153:743–752. https://doi.org/10.1053/j.gastro.2017.05.043
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pinheiro, F.C., Sperb-Ludwig, F. & Schwartz, I.V.D. KHK inhibition for the treatment of hereditary fructose intolerance and nonalcoholic fatty liver disease: a double-edged sword. Cell. Mol. Life Sci. 77, 3465–3466 (2020). https://doi.org/10.1007/s00018-020-03575-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-020-03575-y